COVID-19 News, PROGRAM INTEGRITY—PROPOSED RULES: Transparency, lower costs part of proposed Medicare Part C, D changes, (Jan 12, 2022)

By Cathleen Calhoun, J.D.

CMS looks to improve access and transparency, and to lower costs, under Medicare Advantage (Part C) and Part D drug programs.

CMS is proposing a rule with the goal of lowering out-of-pocket prescription drug prices and improving consumer protections and health disparities under the Medicare Advantage (Part C) and Part D drug pro ...